行情

CDMO

CDMO

Avid Bioservices
NASDAQ

实时行情|Nasdaq Last Sale

6.53
0.00
0.00%
盘后: 6.53 0 0.00% 16:30 01/17 EST
开盘
6.55
昨收
6.53
最高
6.74
最低
6.45
成交量
20.61万
成交额
--
52周最高
8.38
52周最低
3.370
市值
3.68亿
市盈率(TTM)
-38.4344
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CDMO 新闻

  • 小米大涨5%誓要重返17港元招股价 5大因素促使大涨
  • 新浪港股.22分钟前
  • 荔枝上市了,但音频还是好故事吗?
  • 新浪财经综合.29分钟前
  • 特斯拉在美遭投诉 50万辆车涉及“意外加速”风险
  • 界面.59分钟前
  • Airbnb备战IPO:审查700万房源 工资旅客安全挂钩
  • 智通财经网.1小时前

更多

所属板块

制药
+0.13%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

CDMO 简况

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides a variety of process development activities, including cell line development and optimization.
展开

Webull提供Avid Bioservices Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。